Hasil Pencarian - Anouk Déruaz‐Luyet

  • Menampilkan 1 - 17 hasil dari 17
Perbaiki Hasil
  1. 1
    The clinical burden of newly diagnosed Heart failure among patients with Reduced, mildly Reduced, and preserved ejection fraction

    The clinical burden of newly diagnosed Heart failure among patients with Reduced, mildly Reduced, and preserved ejection fraction oleh Gregory A. Nichols, Qing Qiao, Anouk Déruaz-Luyet, Bettina J. Kraus

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.

    Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study. oleh Montserrat Miret, Erzsébet Horváth-Puhó, Anouk Déruaz-Luyet, Henrik Toft Sørensen, Vera Ehrenstein

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Comparing the self-perceived quality of life of multimorbid patients and the general population using the EQ-5D-3L.

    Comparing the self-perceived quality of life of multimorbid patients and the general population using the EQ-5D-3L. oleh Alexandra A N'Goran, Anouk Déruaz-Luyet, Dagmar M Haller, Andreas Zeller, Thomas Rosemann, Sven Streit, Lilli Herzig

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes

    Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes oleh Gregory A. Nichols, Anouk Derúaz-Luyet, Kimberly G. Brodovicz, Teresa M. Kimes, A. Gabriela Rosales, Sibylle J. Hauske

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes

    Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diab... oleh Gregory A. Nichols, Anouk Déruaz-Luyet, Kimberly G. Brodovicz, Teresa M. Kimes, A. Gabriela Rosales, Sibylle J. Hauske

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Family practitioners' top medical priorities when managing patients with multimorbidity: a cross-sectional study

    Family practitioners' top medical priorities when managing patients with multimorbidity: a cross-sectional study oleh Lilli Herzig, Yolanda Mueller, Dagmar M Haller, Andreas Zeller, Stefan Neuner-Jehle, Anouk Déruaz-Luyet, Christine Cohidon, Sven Streit, Bernard Burnand, Jean-Christophe Zuchuat

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Determinants associated with deprivation in multimorbid patients in primary care-A cross-sectional study in Switzerland.

    Determinants associated with deprivation in multimorbid patients in primary care-A cross-sectional study in Switzerland. oleh Silja Leiser, Anouk Déruaz-Luyet, A Alexandra N'Goran, Jérôme Pasquier, Sven Streit, Stefan Neuner-Jehle, Andreas Zeller, Dagmar M Haller, Lilli Herzig, Patrick Bodenmann

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care

    The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care oleh Elisabetta Patorno, Mehdi Najafzadeh, Ajinkya Pawar, Jessica M. Franklin, Anouk Déruaz‐Luyet, Kimberly G. Brodovicz, Adrian J. Santiago Ortiz, Lily G. Bessette, Martin Kulldorff, Sebastian Schneeweiss

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

    Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study oleh Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

    Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study oleh Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Varied treatment patterns among patients with palmoplantar pustulosis: A claims-based cohort study using data from 2 large US databases

    Varied treatment patterns among patients with palmoplantar pustulosis: A claims-based cohort study using data from 2 large US databases oleh Jashin J. Wu, MD, Ran Gao, MS, Rhonda L. Bohn, ScD, Anouk Déruaz-Luyet, PhD, Stephani Gray, MPH, Frank Baehner, MD, Steven R. Feldman, PhD

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databasesCapsule Summary

    Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databasesCapsule Summary oleh Steven R. Feldman, MD, Rhonda L. Bohn, ScD, Ran Gao, MS, Stephani Gray, MPH, Sabrina E. Walton, MSPH, Anouk Déruaz-Luyet, PhD, MPH, Jashin J. Wu, MD

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Varied treatment pathways with no defined treatment sequencing in patients with generalized pustular psoriasis: A claims-based study

    Varied treatment pathways with no defined treatment sequencing in patients with generalized pustular psoriasis: A claims-based study oleh Steven R. Feldman, MD, PhD, Ran Gao, MS, Rhonda L. Bohn, ScD, Stephani Gray, MPH, Sabrina E. Walton, MSPH, Anouk Déruaz-Luyet, PhD, MPH, Jashin J. Wu, MD

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Multimorbidity: can general practitioners identify the health conditions most important to their patients? Results from a national cross-sectional study in Switzerland

    Multimorbidity: can general practitioners identify the health conditions most important to their patients? Results from a national cross-sectional study in Switzerland oleh Anouk Déruaz-Luyet, Alexandra A. N’Goran, Jérôme Pasquier, Bernard Burnand, Patrick Bodenmann, Stefan Zechmann, Stefan Neuner-Jehle, Nicolas Senn, Daniel Widmer, Sven Streit, Andreas Zeller, Dagmar M. Haller, Lilli Herzig

    Diterbitkan 2018-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study

    Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study oleh Dae Jung Kim, Wayne H‐H Sheu, Wook‐Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia‐Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz‐Luyet, Moe H Kyaw, Yutaka Seino, EMPRISE East Asia Study Group

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Healthcare resource utilization in patients treated with empagliflozin in East Asia

    Healthcare resource utilization in patients treated with empagliflozin in East Asia oleh Wayne H‐H Sheu, Yutaka Seino, Elise Chia‐Hui Tan, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Wook‐Jin Chung, Koichi Node, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Anastasia Ustyugova, Riho Klement, Anouk Deruaz‐Luyet, Moe H Kyaw, Dae Jung Kim, the EMPRISE East Asia study group

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study

    Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study oleh Yutaka Seino, Dae Jung Kim, Daisuke Yabe, Elise Chia‐Hui Tan, Wook‐Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Moe H. Kyaw, Anouk Deruaz‐Luyet, Kimberly G. Brodovicz, Wayne H.‐H. Sheu, the EMPRISE East Asia study group

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: